Research Use Only — Confirm to Continue

OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.

By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.

Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

SLU-PP-332 Dosage & Reconstitution

ERR pan-agonist. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

2 mg/mL · 2000 mcg/mL
All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — SLU-PP-332Your Answer

25Draw To This Line
0.25That's This Many mL
10Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 25
5 mg ÷ 2.5 mL = 2 mg/mL  →  500 mcg ÷ 2 mg/mL = 0.25 mL  →  × 100 = 25 units
Looks good. Draw to 25 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 10 doses.

2Week-By-Week Plan — SLU-PP-332

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Research study dose50 mg/kg weight-baseddaily Set by body weight — can't be turned into a single amount to draw
Community reported 250 mcg 1× daily 0.125 mL 12.5 u 20 doses
Community reported upper 500 mcg 1× daily 0.25 mL 25 u 10 doses
Weeks until the top dose
2 weeks
Peptide used getting there
3.5 mg
Vials you'll need
1 × 5 mg
Once you're at the top dose
14 mg / 4 wk · 2.8 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — SLU-PP-332

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Weeks 1–2 250 mcg daily 0.125 mL 12.5 u 14 3.5 mg
Week 3 onward
per 4 weeks from here on
500 mcg daily 0.25 mL 25 u 28 14 mg
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About SLU-PP-332About This Peptide

Metabolic / Incretin
Also known as
ERR pan-agonist
Class
Metabolic / Incretin
Route
Subcutaneous
Half-life
Short
Evidence tier
Preclinical

An estrogen-related receptor pan-agonist described as an exercise mimetic in preclinical models. Not a peptide, no human data of any kind. Reported doses below are the weight-based research figures, given raw rather than converted, because a human-equivalent conversion is not supported.

Buy SLU-PP-332this peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
An ERR agonist that enhances exercise capacity Billon C, et al. Journal of Pharmacology and Experimental Therapeutics / Cell Reports Medicine, 2023–24
The running-capacity study that generated all interest in this compound.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

More peptides

Browse the full catalogue, or jump to a neighbouring compound.

5-Amino-1MQ

A small-molecule NNMT inhibitor rather than a true peptide. Research data show reduced adiposity in diet-induced obesity models. N…

Adipotide

A vascular-targeting peptidomimetic that ablates white adipose vasculature. Research studies showed weight loss alongside dose-dep…

All 71 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.